Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (43)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bastlová, T.
Right arrow Articles by Lambert, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bastlová, T.
Right arrow Articles by Lambert, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

research-article

Styrene oxide-induced HPRT mutations, DNA adducts and DNA strand breaks in cultured human lymphocytes

Tatiana Bastlová 2, Pavel Vodicka 1, Katerrina Peterková 1, Kari Hemminki and Bo Lambert

Center for Nutrition and Toxicology, Karolinska Institute Novum, 14157 Huddinge, Sweden
1Institute of Experimental Medicine, Laboratory of Genetic Ecotoxicology, Czech Academy of Sciences Videnská 1083, 14220 Prague and Regional Institute of Hygiene Dittrichova 17, 12000 Prague 2, Czech Republic

2To whom correspondence should be addressed

Styrene-7,8-oxlde (SO) is the major in vivo metabolite of styrene, a widely used plastic monomer. SO has been classified as probably carcinogenic to humans. We studied the genotoxic effects of SO in human peripheral blood lymphocytes (PBL) in vitro. SO-treatment In the range of 0.05–0.6 mM for 24 h resulted in a dose-dependent decrease of cell survival and increase of HPRT mutation, O6-guanine DNA adducts and DNA strand breaks, whereas higher concentrations caused pronounced cell death. SO was a weak mutagen, inducing at most 10–20 mutants per 106 clonable cells (~4-fold over the background) after treatment with 0.2/0.4 mM for 24 h or 6 days. The levels of DNA adducts in treated cells correlated with SO-concentrations, but only four adducts per 108 nucleotides were detected at the highest treatment concentrations. Yet, adducts were still detectable In cells that had been cultured for 6–8 days after treatment. SO-Induced DNA strand breaks, measured with the Comet assay, were detectable after 1 h exposure to 0.05–0.1 mM. Post-treatment Incubation for 24 h decreased the level of DNA strand breaks to the control level. There was no correlation between the levels of DNA adducts and frequency of HPRT mutation. The present results indicate that SO is relatively inefficient In Inducing HPRT mutation and O6guanine DNA adducts in human lymphocytes in vitro, which may be related to its pronounced cytotoxicity at concentrations above 0.4 mM. A comparison with previous in vivo data obtained by the same assays in T-lymphocytes of styrene-exposed workers suggests that chronic, low dose exposure to styrene in the work environment may be more efficient In Inducing persistent DNA adducts and HPRT mutation than acute, short-term exposure.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
L. Godderis, P Aka, M Kirsch-Volders, and H Veulemans
Comparison of genotoxic potency of styrene 7,8-oxide with {gamma} radiation and human cancer risk estimation of styrene using the rad-equivalence approach
Mutagenesis, May 1, 2007; 22(3): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Boccellino, F. Cuccovillo, M. Napolitano, N. Sannolo, C. Balestrieri, A. Acampora, A. Giovane, and L. Quagliuolo
Styrene-7,8-oxide activates a complex apoptotic response in neuronal PC12 cell line
Carcinogenesis, March 1, 2003; 24(3): 535 - 540.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Extended Abstracts
Toxicol Pathol, November 1, 1997; 25(6): 674 - 696.
[PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.